ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-0.15%
US Tech 100
21,175.20
0.48%
S&P 500
6,083.57
0.36%
US Dollar vs CAD
1.43225
0.11%
Bitcoin
96,970.15
0.41%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lyra Therapeutics Inc (LYRA)

  7. Lyra Therapeutics Inc (LYRA) News

LYRA

Lyra Therapeutics (LYRA)

Lyra Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LYRA
DateTimeSourceHeadlineSymbolCompany
01/10/20253:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
01/10/20253:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
01/10/20253:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
12/13/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
12/11/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
12/11/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
11/14/20246:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LYRALyra Therapeutics Inc
11/14/20244:49PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LYRALyra Therapeutics Inc
11/14/20244:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LYRALyra Therapeutics Inc
11/14/20243:53PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LYRALyra Therapeutics Inc
11/14/202411:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LYRALyra Therapeutics Inc
11/12/20243:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYRALyra Therapeutics Inc
11/12/20243:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
11/12/20243:01PMGlobeNewswire Inc.Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LYRALyra Therapeutics Inc
10/18/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
10/18/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
10/15/20246:00AMGlobeNewswire Inc.Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic RhinosinusitisNASDAQ:LYRALyra Therapeutics Inc
09/27/20246:00AMGlobeNewswire Inc.Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual MeetingsNASDAQ:LYRALyra Therapeutics Inc
08/14/20243:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYRALyra Therapeutics Inc
08/14/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
08/14/20243:01PMGlobeNewswire Inc.Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LYRALyra Therapeutics Inc
07/23/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
06/18/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
06/14/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
06/14/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
06/14/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
06/07/20243:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LYRALyra Therapeutics Inc
05/21/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
05/21/20248:14AMGlobeNewswire Inc.Lyra Therapeutics Announces Cost-Cutting Measures to Preserve CapitalNASDAQ:LYRALyra Therapeutics Inc
05/06/20246:59AMGlobeNewswire Inc.Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic RhinosinusitisNASDAQ:LYRALyra Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LYRA

Your Recent History

USOTC
MCIC
Multicorp (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
HADV
Health Advance (PK)
USOTC
RITE
MineralRite (PK)
USOTC
AFFU
Affluence (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
RDAR
Raadr (PK)
USOTC
PHIL
PHI (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
HHSE
Hannover House (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
ADIA
Adia Nutrition (PK)
USOTC
SPZI
Spooz (PK)
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads